Fortaz in D5W and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Fortaz in D5W and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ceftazidime
Brand name: Fortaz, Tazicef, Ceptaz, Tazidime, Tazicef Novaplus, Tazicef ADD-Vantage, Fortaz ADD-Vantage, Fortaz Twistvial
Synonyms: Fortaz
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fortaz in D5W-Insulin degludec
- Fortaz in D5W-Insulin Degludec (U-100) Prefilled Pens
- Fortaz in D5W-Insulin Degludec (U-100) Vials
- Fortaz in D5W-Insulin Degludec (U-200) Prefilled Pens
- Fortaz in D5W-Insulin degludec and liraglutide
- Fortaz in D5W-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Forteo
- Insulin aspart, recombinant Subcutaneous-Fortesta
- Insulin aspart, recombinant Subcutaneous-Fortesta Gel
- Insulin aspart, recombinant Subcutaneous-Fortical
- Insulin aspart, recombinant Subcutaneous-Fortical Nasal
- Insulin aspart, recombinant Subcutaneous-Fortovase